Weight-loss medicines are changing the food conversation

GLP-1 medicines are changing more than pharmacy conversations. They are also changing how people talk about appetite, weight and the food environment that has long shaped daily choices.

That matters because a treatment can become a cultural signal before its benefits, limits and access are shared evenly. Food makers may respond to changing demand, but a new product line does not settle the harder questions around health, cost or stigma.

The observed shift is not a finished public-health story and it is not a verdict on anyone’s body. It is a change in the cultural frame, with the practical consequences still uneven and unresolved.

Read the full story at The Boston Globe (Opinion) ↗